Olaparib combined with low-dose chemotherapy for relapsed positive acute myeloid leukemia in elderly patient.
作者信息
Lin Li, Xue Song, Chen Jiaqi, Gu Cuihong, Zhang Jingzheng, Xing Enhong, Wang Wei, Wang Lihong, Zhang Zhihua
机构信息
Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.
Department of Bone Marrow Transplant, Beijing Lu Daopei Hospital, Beijing, People's Republic of China.
出版信息
Leuk Lymphoma. 2024 Aug;65(8):1181-1185. doi: 10.1080/10428194.2024.2337795. Epub 2024 Jul 23.
Abstract
摘要
相似文献
1
Olaparib combined with low-dose chemotherapy for relapsed positive acute myeloid leukemia in elderly patient.奥拉帕利联合低剂量化疗用于老年复发阳性急性髓系白血病患者
Leuk Lymphoma. 2024 Aug;65(8):1181-1185. doi: 10.1080/10428194.2024.2337795. Epub 2024 Jul 23.
2
Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO.用AML1-ETO治疗初发急性髓系白血病后AML1-ETO与PML-RARa的共表达
Leuk Lymphoma. 2019 May;60(5):1316-1319. doi: 10.1080/10428194.2018.1520991. Epub 2018 Oct 17.
3
Combined use of interferon alpha-1b, interleukin-2, and thalidomide to reverse the AML1-ETO fusion gene in acute myeloid leukemia.联合使用干扰素 alpha-1b、白细胞介素-2 和沙利度胺逆转急性髓系白血病中的 AML1-ETO 融合基因。
Ann Hematol. 2021 Oct;100(10):2593-2601. doi: 10.1007/s00277-021-04621-w. Epub 2021 Jul 27.
4
Relapsed RUNX1-RUNX1T1-positive acute myeloid leukemia with pseudo-Chediak-Higashi granules.伴有假性齐-希二氏颗粒的复发性RUNX1-RUNX1T1阳性急性髓系白血病。
Int J Hematol. 2021 May;113(5):616-617. doi: 10.1007/s12185-021-03141-7. Epub 2021 Mar 29.
5
FACSorting help to analyze a rare case of acute myeloid leukemia with concurrent AML1-ETO and PML-RARA.荧光激活细胞分选术有助于分析一例同时存在AML1-ETO和PML-RARA的急性髓系白血病罕见病例。
Int J Lab Hematol. 2021 Dec;43(6):e276-e279. doi: 10.1111/ijlh.13558. Epub 2021 May 4.
6
Histone deacetylase 3 preferentially binds and collaborates with the transcription factor RUNX1 to repress AML1-ETO-dependent transcription in t(8;21) AML.组蛋白去乙酰化酶 3 优先与转录因子 RUNX1 结合并协同作用，以抑制 t(8;21) AML 中 AML1-ETO 依赖性转录。
J Biol Chem. 2020 Mar 27;295(13):4212-4223. doi: 10.1074/jbc.RA119.010707. Epub 2020 Feb 18.
7
Homoharringtonine may help improve the outcomes of venetoclax and azacitidine in AML1-ETO positive acute myeloid leukemia.高三尖杉酯碱可能有助于改善 AML1-ETO 阳性急性髓系白血病患者中维奈托克和阿扎胞苷的疗效。
J Cancer Res Clin Oncol. 2024 Jul 6;150(7):336. doi: 10.1007/s00432-024-05861-9.
8
[Co-existence of AML1-ETO and BCR-ABL1 fusion genes in acute myeloid leukemia: a case report].
Zhonghua Nei Ke Za Zhi. 2024 Feb 1;63(2):203-206. doi: 10.3760/cma.j.cn112138-20230815-00059.
9
MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.MEIS2 是 AML1-ETO 阳性 AML 的致癌伙伴。
Cell Rep. 2016 Jul 12;16(2):498-507. doi: 10.1016/j.celrep.2016.05.094. Epub 2016 Jun 23.
10
Simultaneous occurrence of two distinct leukemic clones with PML-RARα and RUNX1-RUNX1T1 in a case of acute myeloid leukemia.1例急性髓系白血病中同时出现具有PML-RARα和RUNX1-RUNX1T1的两种不同白血病克隆。
Ann Hematol. 2018 Mar;97(3):529-531. doi: 10.1007/s00277-017-3169-5. Epub 2017 Nov 9.
Zotero 插件